Skip to content
Scintria
ToolsGrant writerFunding
HomeLiteratureClinical trialsEvidence LabProtocol packData analysisLearnProjectsLibraryReferencesApplications
Start free
ScintriaStart free

Learn / Clinical Research Management / The protocol and study start-up

Feasibility and site selection

12 minute read · 6-question quiz

Download this lesson as a colour Word or PDF study guide with the figures and answers. Included in paid plans; reading and quizzes stay free.Sign in

What you will learn

  • Assess whether a trial is feasible in a country and at a site

  • Calculate recruitment targets, screen failure and attrition allowances

  • Describe site qualification and what a pre-study visit examines

Many trials fail not for scientific reasons but because they cannot recruit or run to plan. Feasibility assessment tests whether the study can be done as designed before committing time and money.

Feasibility questions

  • Patient availability: how many eligible patients attend per month, and how many would consent?
  • Competing trials in the same population.
  • Investigator experience, interest and time.
  • Staff and facilities: trained staff, laboratory, pharmacy, storage, freezers, internet and power backup.
  • Regulatory and ethics timelines in the country.
  • Standard of care that might differ from the protocol.
  • Logistics: courier access, import of products and samples, temperature-controlled transport.

Site selection and qualification

After a feasibility questionnaire, the sponsor or CRO may visit shortlisted sites in a pre-study visit (also called site qualification visit). It checks the PI's qualifications and GCP training, staff, facilities, patient population, record keeping, previous inspection history and regulatory experience. The outcome is a recommendation to select or decline.

Planning recruitment

Number to screen = (target randomised)/(1 - screen failure rate)

Number to randomise = (evaluable participants needed)/(1 - drop-out rate)

Months of recruitment = (number to randomise)/(sites × rate per site per month)

Worked example: how many to screen?

A trial needs 200 evaluable participants. Past similar trials had 15% drop-out and 30% screen failure.

  • To randomise: 200 / (1 − 0.15) = 200 / 0.85 = 236 (rounding up).
  • To screen: 236 / (1 − 0.30) = 236 / 0.70 = 337.

With 8 sites each randomising an average of 2 participants per month, recruitment takes 236 / (8 × 2) = 14.75, about 15 months. If only 1.5 per month are achieved, it takes 236 / 12 = 19.7, about 20 months. A realistic rate matters more than an optimistic one.

337Screened101 (30%)Screen failures236Randomised36 (15%)Drop-outs200Evaluable
From screening to evaluable participants. Plan the front of the funnel for the losses.

Common reasons sites under-recruit

  • Overestimated patient numbers, based on registers rather than actual eligible attendees.
  • Strict criteria that few patients meet.
  • Competing studies for the same patients.
  • Heavy visit schedules that put people off.
  • Limited staff time for study tasks beyond clinical duties.

Mitigation: realistic estimates from clinic records, early site support, referral networks, community engagement, flexible visit options and regular recruitment tracking with action plans.

Under-promise on feasibility

Sites that give honest, conservative numbers and meet them are worth more to sponsors than sites that promise large numbers and miss them.

The 'historical register' trap

A register lists patients seen over years. It does not tell you how many are currently eligible, willing, within the age range and not on prohibited drugs.

Check yourself

For a study in your clinic, estimate how many eligible patients attend per month, then apply a realistic consent rate and screen failure rate. What is the true monthly rate?

Summary

  • Feasibility assessment tests patients, staff, facilities, timelines and competition before commitment.

  • Site qualification examines the PI, staff, facilities, patients and record keeping.

  • Plan to screen more than you randomise, and randomise more than you need evaluable.

  • Realistic recruitment rates prevent costly delays.

Check your understanding

Question 1
1

200 evaluable participants are needed with 20% drop-out. The number to randomise is:

Question 2
2

A pre-study visit assesses:

Question 3
3

To randomise 236 with 30% screen failure, the number to screen is about:

Question 4
4

A common cause of under-recruitment is:

Question 5
5

Which is NOT usually a feasibility question?

Question 6
6

Eight sites each randomise 2 per month. How many are randomised per month in total?

Draft study guide. Spotted an error or something unclear? Tell us at hello@scintria.com. This is educational material, not clinical or regulatory advice.

The clinical trial protocolStudy start-up: contracts, budgets and the site initiation visit